A Staged Phase 3 Study, Including a Double-Blinded Controlled Stage to Evaluate the Safety and Immunogenicity of Ad26.ZEBOV and MVA-BN-Filo as Candidate Prophylactic Vaccines for Ebola
Phase of Trial: Phase III
Latest Information Update: 12 Oct 2017
At a glance
- Drugs Ad26 EBOV vaccine (Primary) ; Modified Vaccinia Ankara Bavarian Nordic Ebola Marburg vaccine
- Indications Ebola virus infections
- Focus Adverse reactions; Pharmacodynamics
- Acronyms EBOVAC-Salone
- Sponsors Janssen Vaccines and Prevention
- 09 Oct 2017 Planned End Date changed from 12 May 2019 to 13 May 2019.
- 09 Oct 2017 Planned primary completion date changed from 30 Sep 2018 to 3 May 2019.
- 21 Mar 2017 Planned number of patients changed from 728 to 1019.